Acadia Pharmaceuticals (ACAD) EBT (2010 - 2026)
Acadia Pharmaceuticals' EBT was $46.5 million in Q2 2026, up 15.6% from $40.21 million a year earlier.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) EBT (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Acadia Pharmaceuticals' EBT was $121.4 million through Jun 30, 2026, down 54.7% year-over-year; for FY2025, it came in at $138.9 million, down 46.2% from FY2024.
- In earlier years, EBT was $258.08 million in FY2024, -$51.04 million in FY2023, -$213.44 million in FY2022 and -$167.52 million in FY2021.
- The Q2 2026 figure marks the highest quarterly EBT since Q4 2024.
- Compared with a year earlier, EBT was higher in five of the last seven quarters, with growth averaging 29.6%.
- The best year-over-year quarter for EBT over five years was Q2 2024 (growth of 486.5%); the worst was Q1 2026 (a decline of 85.6%).
- Per Business Quant data, ACAD's EBT in the three quarters before Q2 2026 was $4 million (Q1 2026), $26.3 million (Q4 2025) and $44.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.24 Bn | 1,102.83 Bn | 19.71 Bn | 9.25 Bn |
| 2 | Johnson & Johnson | 616.11 Bn | 534.64 Bn | 17.26 Bn | 6.75 Bn |
| 3 | AbbVie | 501.21 Bn | 474.32 Bn | 12.70 Bn | 4.28 Bn |
| 4 | Merck | 367.51 Bn | 321.89 Bn | 12.21 Bn | -683.00 Mn |
| 5 | Novartis Ag | 297.95 Bn | 261.94 Bn | 11.24 Bn | 4.27 Bn |
| 6 | Astrazeneca | 261.35 Bn | 235.03 Bn | 12.86 Bn | 2.80 Bn |
| 7 | Amgen | 235.88 Bn | 191.28 Bn | 7.24 Bn | 2.77 Bn |
| 8 | Gilead Sciences | 190.74 Bn | 164.94 Bn | 6.22 Bn | -10.25 Bn |
| 9 | Pfizer | 169.40 Bn | 116.05 Bn | 10.94 Bn | -653.00 Mn |
| 10 | Acadia Pharmaceuticals | 3.47 Bn | -4.82 Mn | 279.64 Mn | 46.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46.50 Mn |
| Mar 31, 2026 | 4.00 Mn |
| Dec 31, 2025 | 26.30 Mn |
| Sep 30, 2025 | 44.60 Mn |
| Jun 30, 2025 | 40.21 Mn |
| Mar 31, 2025 | 27.80 Mn |
| Dec 31, 2024 | 161.08 Mn |
| Sep 30, 2024 | 38.81 Mn |
| Jun 30, 2024 | 37.20 Mn |
| Mar 31, 2024 | 21.00 Mn |
| Dec 31, 2023 | 39.70 Mn |
| Sep 30, 2023 | -52.14 Mn |
| Jun 30, 2023 | 6.34 Mn |
| Mar 31, 2023 | -44.94 Mn |
| Dec 31, 2022 | -40.84 Mn |
| Sep 30, 2022 | -26.42 Mn |
| Jun 30, 2022 | -33.60 Mn |
| Mar 31, 2022 | -112.60 Mn |
| Dec 31, 2021 | -42.91 Mn |
| Sep 30, 2021 | -14.79 Mn |
API Access
Acadia Pharmaceuticals EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();